Concepedia

Xuepeng Ju

XJ

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2023

Affiliations

Betta Pharmaceuticals (China)(Current)

Xuepeng Ju is an author at Betta Pharmaceuticals (China) specializing in targeted cancer therapy, oncogenic signaling pathways, and yap and taz signaling.

Publications per year

2023–2023

1

Publications

1

Abstract 501: Discovery of BPI-460372, a potent and selective inhibitor of TEAD for the treatment of solid tumors harboring Hippo pathway aberrations

Hongling Shen, Xiaofeng Xu, Hongfei Rong et al. · Cancer Research · 2023 · 11 citations

, , +14

1–1 of 1